Benzinga | Mar 29, 2021 07:32AM EDT

JonesTrading Initiates Coverage On Ocuphire Pharma with Buy Rating, Announces Price Target of $20

JonesTrading analyst Prakhar Agrawal initiates coverage on Ocuphire Pharma (NASDAQ:OCUP) with a Buy rating and announces Price Target of $20.